Recent

  • Show all results for ""

🎧 New: AI-Generated Podcasts Turn your study notes into engaging audio conversations. Learn more

Lung Disease Patient Identification
41 Questions
0 Views

Lung Disease Patient Identification

Created by
@SupportedTantalum

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What percentage of lung nodules are benign?

  • 95% (correct)
  • 35%
  • 62%
  • 65%

    • What stage are most malignant nodules?

  • Stage I (correct)
  • Stage III
  • Stage II
  • Stage IV

    • What percentage of biopsies are on benign nodules?

  • 70%
  • 62% (correct)
  • 35%
  • 50%

    • What percentage of surgeries are on benign nodules?

    <p>35%</p> Signup and view all the answers

    What percentage of patients sent to CT surveillance have lung cancer?

    <p>17%</p> Signup and view all the answers

    How long does NODIFY LUNG TESTING take to produce results?

    <p>One day</p> Signup and view all the answers

    What is the name of the guidelines used for new 8 to 30 mm pulmonary nodules?

    <p>ACCP Guidelines</p> Signup and view all the answers

    What is the purpose of NODIFY LUNG TESTING?

    <p>To reclassify risk of malignancy</p> Signup and view all the answers

    What percentage of patients moved into the very low-risk group?

    <p>65%</p> Signup and view all the answers

    Which category identifies patients who may benefit from CT surveillance?

    <p>Very Low Risk</p> Signup and view all the answers

    What percentage of patients are in the High Risk category?

    <p>35%</p> Signup and view all the answers

    How many weeks does it take to get the results?

    <p>1 week</p> Signup and view all the answers

    What percentage of patients are Low to Moderate Risk?

    <p>35%</p> Signup and view all the answers

    What is the percentage of patients who are less likely to undergo unnecessary procedures according to the Nodify XL2 test?

    <p>74%</p> Signup and view all the answers

    What is the importance of nodule size in predicting the risk of malignancy?

    <p>It is as important as plasma protein levels</p> Signup and view all the answers

    What is the performance of the Likely Benign result reflected by?

    <p>30% negative predictive value</p> Signup and view all the answers

    What is the cost of Nodify lung testing for Medicare beneficiaries?

    <p>It is $0 out of pocket</p> Signup and view all the answers

    What is the percentage of nodules that are likely to be benign according to the Nodify XL2 test?

    <p>97%</p> Signup and view all the answers

    What is the risk of malignancy for this patient after the Nodify XL2 test?

    <p>3%</p> Signup and view all the answers

    What is the clinical risk factor associated with a 7.3% decrease in invasive procedures?

    <p>Location</p> Signup and view all the answers

    What is the purpose of the Nodify XL2 test?

    <p>To reduce invasive procedures on benign nodules</p> Signup and view all the answers

    What percentage of reported results indicate a high level of autoantibodies detected?

    <p>5%</p> Signup and view all the answers

    What is the recommended action for patients with a solitary pulmonary nodule (SPN) of 8-30 mm?

    <p>Nodify CDT testing</p> Signup and view all the answers

    Which of the following is NOT a condition for Nodify XL2 testing eligibility?

    <p>Patient has a biopsy-proven lung cancer</p> Signup and view all the answers

    What is the recommended method for coordinating the blood draw for Nodify CDT testing?

    <p>All of the above</p> Signup and view all the answers

    How long does it take to receive Nodify CDT results if the test is positive?

    <p>1 day</p> Signup and view all the answers

    What percentage of reported results indicate a moderate level of autoantibodies detected?

    <p>10%</p> Signup and view all the answers

    How can the Solitary Pulmonary Nodule Calculator be accessed?

    <p>On the Biodesix website</p> Signup and view all the answers

    What is the recommended course of action for patients at high risk of malignancy?

    <p>Timely intervention</p> Signup and view all the answers

    How are patients informed about the Nodify testing process?

    <p>During an in-office consultation</p> Signup and view all the answers

    What is the purpose of the Test Request Form (TRF)?

    <p>To coordinate the blood draw</p> Signup and view all the answers

    What is the primary purpose of the Nodify CDT test?

    <p>To identify patients with likely malignant lung nodules</p> Signup and view all the answers

    What type of antigens are measured by the Nodify CDT test?

    <p>Tumor-associated antigens</p> Signup and view all the answers

    What is the significance of a High Level result in the Nodify CDT test?

    <p>It indicates a high risk of malignancy</p> Signup and view all the answers

    What is the clinical risk factor associated with the patient's 4 mm solid nodule?

    <p>Current smoker</p> Signup and view all the answers

    What is the post-Nodify CDT risk of malignancy for the patient?

    <p>85%</p> Signup and view all the answers

    What is the purpose of the Nodify XL2 test?

    <p>To identify patients with likely benign lung nodules</p> Signup and view all the answers

    What is the significance of the specificity of the Nodify CDT test?

    <p>It reflects the performance of the High Level result</p> Signup and view all the answers

    What is the timeframe for receiving Nodify CDT test results?

    <p>One day</p> Signup and view all the answers

    What is the relationship between the pre-test risk of malignancy and the post-Nodify CDT risk of malignancy?

    <p>The post-Nodify CDT risk is higher</p> Signup and view all the answers

    What is the benefit of using the Nodify CDT test?

    <p>All of the above</p> Signup and view all the answers

    Study Notes

    Nodify Lung Testing

    • 95% of lung nodules are benign.
    • Current diagnostic pathways for 8-30 mm lung nodules involve CT surveillance, biopsy, or surgery, with 62% of biopsies and 35% of surgeries on benign nodules.
    • Nodify lung testing is a blood-based testing strategy to help reclassify the risk of malignancy in lung nodules.
    • The test measures autoantibodies associated with lung cancer to detect lung cancer across histologies and stages.

    Clinical Risk Factors

    • Location
    • Spiculation
    • Smoking history
    • Age
    • Nodule size

    Nodify CDT Test

    • Designed to help identify patients with likely malignant lung nodules.
    • Measures autoantibodies to tumor-associated antigens (P53, CAGE, NY-ESO-1, GBU4-5, MAGE A4, SOX2, HuD).
    • Results are presented as a personalized risk of malignancy to support shared decision making and reduce patient anxiety.

    Nodify XL2 Test

    • Designed to help identify patients with likely benign lung nodules.
    • Detects plasma protein levels associated with lung cancer.
    • Results are presented as a personalized risk of malignancy.

    Nodify Lung Results

    • 85% of reported results are likely benign.
    • 10% of reported results are reduced risk.
    • 5% of reported results are high risk.
    • Results can be easily incorporated into clinical workflows.

    Ordering and Receiving Results

    • Order Nodify lung testing for patients with solitary or multiple nodules.
    • Receive results in one day or one week, depending on the test.
    • Use the results to inform care plans, including CT surveillance, biopsy, or surgery.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Identify patients and order tests to receive results with NODIFY LUNG. This quiz helps you understand how to incorporate lung disease identification into clinical workflows.

    More Quizzes Like This

    Respiratory Diseases Quiz
    5 questions

    Respiratory Diseases Quiz

    YouthfulSelenite1404 avatar
    YouthfulSelenite1404
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser